ABMTAdvanced BioMedical Technologies Inc.
Sep 30, 2026 — SEC Reporting Compliance & Deregistration Decision
Chart by TradingViewThe schedule
- Wed30Sep
Evaluation of SEC registration revocation risk given multi-year filing delinquencies under the current administration. Modeled at a base price of $0.0001, looking to a $0.0002 target and a $0.0000 fallback.
